The IBI Ag team (Credit: IBI Ag)
IBI Ag, a trailblazer in crop protection and an Israeli startup, is revolutionizing the agricultural landscape with its cutting-edge bio-insecticides designed for maximum impact and minimal environmental harm. Today, the company announced a major milestone—securing $6.1 million in the initial close of its highly anticipated Series A funding round.
This pivotal investment, spearheaded by agricultural giant Corteva, Inc. through its Corteva Catalyst platform, with strong backing from The Trendlines Group, Iron Nation, Consensus Business Group, and a prestigious grant from the Israel Innovation Authority, highlights the soaring demand for sustainable, nature-inspired crop protection solutions. As the global agricultural sector faces mounting pressure to feed a growing population while safeguarding the planet, IBI Ag’s groundbreaking innovations stand at the forefront, empowering farmers to protect their crops, enhance yields, and fortify the world’s food supply.
Founded in 2017, by The Trendlines Group, along with founders Amir Ayali, PhD, and Rony Oren Benaroya, PhD, IBI-Ag is supported by the Israel Innovation Authority. IBI-Ag is a pioneering Agri-biotech company, revolutionizing crop protection with innovative and sustainable solutions. Their unique, first-of-its-kind technology platform uses nano-bodies (a type of antibody) to develop effective, selective, and safe biological insect control. This breakthrough has the potential to safeguard the global food supply by enabling farmers to protect crops with a reduced environmental impact. IBI-Ag’s eco-friendly and cost-effective alternative to chemical pesticides promises to transform the agricultural industry.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.
IBI Ag has harnessed the power of single-domain antibody technology to create groundbreaking crop protection solutions with a minimal ecological footprint. Originally derived from pharmaceutical advancements and expertly adapted for agriculture, this cutting-edge approach introduces novel modes of action, revolutionizing insect control.
Designed to combat a wide range of pests—including both sucking and chewing insects—IBI Ag’s innovative products provide powerful protection while minimizing harm to non-target organisms. The company is initially focusing on high-value crops, with plans to expand into row crops, ushering in a new era of sustainable and highly effective pest management.
“We are thrilled to have the support of our existing and new investors, led by Corteva through their Corteva Catalyst platform,” said Arnon Heyman, Chief Executive Officer, IBI Ag. “This investment will help us to accelerate the development of our single domain antibody technology, providing farmers with sustainable and effective crop protection solutions. We believe our single domain antibody technology is a game changer for driving agricultural productivity while preserving the environment, and the investment announced today is a significant step towards delivering this innovation to farmers across the globe.”
